SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-03-016558
Filing Date
2003-05-05
Accepted
2003-05-05 08:17:55
Documents
2
Period of Report
2003-05-05
Items
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a2110061z8-k.txt 8-K 3444
3 EXHIBIT 99.1 a2110061zex-99_1.txt EX-99.1 10687
  Complete submission text file 0001047469-03-016558.txt   15671
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 03680992
SIC: 2836 Biological Products, (No Diagnostic Substances)